The journal
Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.
The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.
With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.
Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
Editor in Chief
Anders Elm Pedersen , University of Copenhagen
Associate Editors
Minoru Satoh, University of Occupational and Environmental Health, Fukuoka, Japan
Ron Taylor, University of Virginia, Charlottesville, VA, USA
Editorial Board
Allergy
Didier Ebo, University of Antwerp, Belgium
Lars K Poulsen, University of Copenhagen
Chronic Inflammation and Autoimmunity
Yoshio Kumazawa, Kitasato University, Tokyo, Japan
Antonio La Cava, University of California Los Angeles, Los Angeles, CA, USA
Timothy Radstake, University Medical Centre Utrecht & Clinical Immunology, Utrecht, The Netherlands
Minoru Satoh, University of Occupational and Environmental Health, Fukuoka, Japan
Cytotherapies
Anders Elm Pedersen, University of Copenhagen, Denmark
Dermatology
Yoshinao Muro, Nagoya University Graduate School of Medicine, Nagoya, Japan
Diabetes
Dan Holmberg, University of Lund, Sweden
Drug Discovery and Development
Carlo Riccardi, University of Perugia, Perugia, Italy
Immunomodulators from Medicinal Plants
Wen-Chin Yang, Academia Sinica, Taipei, Taiwan
Microbial Immunomodulators
Haruhiko Takada, Tohoku University, Sendai, Japan
Mucosal Immunity, Vaccines
Frederik van Ginkel, Auburn University, Auburn, AL, USA
Neuroimmunology
Alon Monsonego, The National Institute of Biotechnology, Beer-Shevam, Israel
Francesco Roselli, University of Bari, Bari, Italy
Nutritious Immunology and Immunology Animal Production
Pietro Celi, DSM Nutritional Products Inc. (nutrition)
Erling Koppang, Norwegian School of Veterinary Science, Oslo (animal production)
Thea Magrone, Department of Basic Medical Sciences, University of Bari, Bari (nutrition)
Tumor Immunology
Roland Meier, Brookline, MA, USA
Steve Ralph, Griffith University, Southport, QLD, Australia
Ron Taylor, University of Virginia, Charlottesville, VA, USA
Akira Yamada, Research Center for Innovative Cancer Therapy Kurume University, Kurume Fukuoka, Japan
Immunopharmacology and Immunotoxicology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})